Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 24:26:53-58.
doi: 10.1016/j.nmni.2018.08.007. eCollection 2018 Nov.

First report of colistin resistance among carbapenem-resistant Acinetobacter baumannii isolates recovered from hospitalized patients in Egypt

Affiliations

First report of colistin resistance among carbapenem-resistant Acinetobacter baumannii isolates recovered from hospitalized patients in Egypt

Amani T Abdulzahra et al. New Microbes New Infect. .

Abstract

Acinetobacter baumannii is an opportunistic pathogen that poses an increasing threat in the health-care community. Colistin is one of the promising options for treatment of multidrug-resistant A. baumannii. The current study investigated the emergence of colistin resistance among carbapenem-resistant strains of A. baumannii in Egypt. It involved identification of clinically recovered A. baumannii isolates using the VITEK-2 system, and screening of their antimicrobial susceptibilities using broth microdilution techniques. Characterizations of carbapenemase and 16S rRNA methyltransferase genes were performed using PCR. Colistin-resistance determinants were characterized by sequencing. Carbapenem-resistant A. baumannii isolates (n = 40) showed resistance to amoxicillin-clavulanic acid, cefotaxime, gentamicin and amikacin. Most isolates revealed resistance to ciprofloxacin (95%; n = 38) and co-trimoxazole (92.5%; n = 37). Resistance to tobramycin and doxycycline was 80% (n = 32) and 62.5% (n = 25), respectively. Only two A. baumannii isolates demonstrated colistin resistance. Carbapenemase activity was tested by modified Hodge test and 78% of isolates were positive. All isolates carried blaOXA-51-like genes whereas bla-OXA-23 was detected in 80% (n = 32) of isolates. Among 16S rRNA methylase genes, armA was detected in 22.5% (n = 9) of the isolates. Analyses of lpxA, lpxC, lpxD and pmrCAB genetic sequences suggest that colistin resistance could be attributed to mutations in pmrCAB genes. Alarmingly, colistin resistance was associated with high levels of resistance to other antimicrobials. The current findings represent a serious health-care problem capable of restraining future therapeutic options.

Keywords: Acinetobacter baumannii; armA; blaOXA-23; colistin resistance; pmrABCgenes.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Multiplex PCRs for detection of blaOXA carbapenemase genes. First lane represents DNA marker (100-bp DNA ladder). The agarose gel illustrates that Acinetobacter baumannii strains A101, A102, A105, A106 and A107 are positive for both blaOXA-23 and blaOXA-51; A. baumannii A103 and A104 are blaOXA-23 gene negative.

Similar articles

Cited by

References

    1. Arroyo L.A., Garcia-Curiel A., Pachon-Ibanez M.E., Llanos A.C., Ruiz M., Pachon J. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J Clin Microbiol. 2005;43:903–905. - PMC - PubMed
    1. Arroyo L.A., Herrera C.M., Fernandez L., Hankins J.V., Trent M.S., Hancock R.E. The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A. Antimicrob Agents Chemother. 2011;55:3743–3751. - PMC - PubMed
    1. Bassetti M., Righi E., Esposito S., Petrosillo N., Nicolini L. Drug treatment for multidrug-resistant Acinetobacter baumannii infections. Future Microbiol. 2008;3:649–660. - PubMed
    1. Beceiro A., Llobet E., Aranda J., Bengoechea J.A., Doumith M., Hornsey M. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob Agents Chemother. 2011;55:3370–3379. - PMC - PubMed
    1. Bonomo R.A., Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis. 2006;43(Suppl. 2):S49–S56. - PubMed

LinkOut - more resources